Sources | Names Used |
---|---|
GDSC1000 | Tivozanib |
CTRPv2 | tivozanib |
PharmacoGx | tivozanib |
Database | Identifier |
---|---|
Smiles: | CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl |
Inchikey: | SPMVMDHWKHCIDT-UHFFFAOYSA-N |
Pubchem: | 9911830 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FAM96B | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
mRNA | FBXO3 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.006 |
mRNA | SAMD9 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
mRNA | MMS19 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
mRNA | TCP11L2 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |
mRNA | NUCB2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
mRNA | CRB3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.006 |
mRNA | COASY | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
mRNA | ATXN3 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.006 |
mRNA | PRKD2 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |